Table 2.

Relationship between eosinophils and the SAP/functional outcome among patients with acute ischemic stroke in different models.

Variable	Non-Adjusted model		Model 1		Model 2
	β/OR (95% CI)	P-Value	β/OR (95% CI)	P-Value	β/OR (95% CI)	P-Value
SAP	0.00 (0.00, 0.01)	0.0010	0.00 (0.00, 0.02)	0.0014	0.00 (0.00, 0.38)	0.0267
mRS	−12.43 (−17.26, −7.60)	<0.0001	−11.30 (−15.89, −6.71)	<0.0001	−5.36 (−9.24, −1.48)	0.0072
Poor outcome (mRS score 3–6)	0.00 (0.00, 0.00)	<0.0001	0.00 (0.00, 0.00)	0.0001	0.00 (0.00, 0.14)	0.0124

Non-adjusted model: we did not adjust other covariates.

Model 1: we adjusted for age and female gender.

Model 2: we adjusted variables that were significantly associated with outcomes of interest (P < 0.10) or changed the estimates of eosinophils on outcomes of interest by more than 10% (Tables II–V in Appendix A).

mRS, modified Rankin Scale; OR, odds ratio; SAP, stroke-associated pneumonia.